Sale!

MECP2 Gene Angelman-like syndrome Genetic Test

4,400 د.إ

-21%

The MECP2 gene Angelman-like syndrome genetic test is a specialized diagnostic procedure aimed at identifying mutations in the MECP2 gene, which are associated with conditions resembling Angelman syndrome. Angelman-like syndromes are a group of neurodevelopmental disorders that share similar characteristics with Angelman syndrome but are caused by genetic abnormalities in different genes, including MECP2. Symptoms of these conditions can include developmental delays, speech impairments, seizures, and unique behaviors such as frequent laughter or smiling.

This test is particularly crucial for individuals showing symptoms of Angelman syndrome but without the typical genetic markers for that condition. By analyzing the MECP2 gene, healthcare professionals can accurately diagnose the presence of Angelman-like syndrome, enabling them to provide targeted interventions and support to patients and their families.

Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the MECP2 gene Angelman-like syndrome genetic test costs 4400 AED. The lab ensures precise and reliable results, thanks to its use of cutting-edge technology and adherence to stringent quality control measures. Opting for this test at DNA Labs UAE offers patients and healthcare providers a critical tool in the diagnosis and management of Angelman-like syndromes, paving the way for improved outcomes and quality of life for affected individuals.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MECP2 Gene Angelman-like syndrome Genetic Test

Components: MECP2 Gene Angelman-like syndrome Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MECP2 Gene Angelman-like syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MECP2 Gene Angelman-like syndrome.

Test Details

The MECP2 gene Angelman-like syndrome NGS genetic test is a diagnostic test that analyzes the MECP2 gene for mutations or changes that may cause Angelman-like syndrome. Angelman-like syndrome is a rare genetic disorder that shares many of the clinical features of Angelman syndrome but is caused by mutations in different genes. The MECP2 gene provides instructions for making a protein that is essential for the normal development and function of the brain. Mutations in this gene can disrupt the production or function of the protein, leading to neurological problems and developmental delays.

NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the rapid and accurate analysis of DNA sequences. The MECP2 gene Angelman-like syndrome NGS genetic test uses this technology to analyze the entire coding region of the MECP2 gene, as well as nearby non-coding regions that may contain regulatory elements. The test can detect a wide range of mutations, including small deletions or insertions, single nucleotide changes, and larger structural variants.

The MECP2 gene Angelman-like syndrome NGS genetic test is typically ordered by a healthcare provider when there is suspicion of Angelman-like syndrome based on clinical symptoms. The test may also be recommended for individuals with a family history of the condition or for those who have previously tested negative for other genetic causes of Angelman-like syndrome. The results of the test can help confirm a diagnosis, guide treatment and management decisions, and provide information for genetic counseling and family planning.

Test Name MECP2 Gene Angelman-like syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MECP2 Gene Angelman-like syndrome NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MECP2 Gene Angelman-like syndrome
Test Details

MECP2 gene Angelman-like syndrome NGS genetic test is a diagnostic test that analyzes the MECP2 gene for mutations or changes that may cause Angelman-like syndrome. Angelman-like syndrome is a rare genetic disorder that shares many of the clinical features of Angelman syndrome but is caused by mutations in different genes. The MECP2 gene provides instructions for making a protein that is essential for the normal development and function of the brain. Mutations in this gene can disrupt the production or function of the protein, leading to neurological problems and developmental delays.

NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the rapid and accurate analysis of DNA sequences. The MECP2 gene Angelman-like syndrome NGS genetic test uses this technology to analyze the entire coding region of the MECP2 gene, as well as nearby non-coding regions that may contain regulatory elements. The test can detect a wide range of mutations, including small deletions or insertions, single nucleotide changes, and larger structural variants.

The MECP2 gene Angelman-like syndrome NGS genetic test is typically ordered by a healthcare provider when there is suspicion of Angelman-like syndrome based on clinical symptoms. The test may also be recommended for individuals with a family history of the condition or for those who have previously tested negative for other genetic causes of Angelman-like syndrome. The results of the test can help confirm a diagnosis, guide treatment and management decisions, and provide information for genetic counseling and family planning.